Background. Majority of prostate cancer (PCa) deaths are attributed to localized high‐grade
aggressive tumours which progress rapidly to metastatic disease. A critical unmet need in …

Prostate cancer (PCa) is the most common diagnosed malignancy and the second leading
cause of cancer‐related deaths among men in the USA. Advances in high‐throughput …

Background. A majority of prostate cancers (PCas) are indolent and cause no harm even
without treatment. However, a significant proportion of patients with PCa have aggressive …

Prostate cancer (PC) is the most frequently diagnosed non-skin cancer in the world.
Previous studies showed that genomic alterations represent the most common mechanism …

The pathological molecular events occurring during prostate cancer (PCa) progression have
not been comprehensively investigated. It remains elusive how genomic aberration is …

Abstract Background Prostate cancer (PCa) is the most common diagnosed malignancy and
the second leading cause of cancer-related deaths among men in the United States. High …

Background Global disparities in prostate cancer (PCa) incidence highlight the urgent need
to identify genomic abnormalities in prostate tumors in different ethnic populations including …

Prostate cancer (PCa), a common malignancy in men, presents a complex and variable
disease landscape, requiring precise evaluation for personalized treatment decisions …

Prostate cancer is the second most common cancer in men in the United States, and racial
disparities are greatly observed in the disease. Specifically, African American (AA) patients …

Cancer arises following alterations at different cellular levels, including genetic and
epigenetic modifications, transcription and translation dysregulation, as well as metabolic …